Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sukru Atakan"'
Autor:
Hulya Bayiz, Sukru Atakan, Burçak Vural, Ali O. Gure, Azmi Serhat Yildirim, Alper Poyraz, Serpil Dizbay Sak, Funda Demirag
Publikováno v:
BMC Clinical Pathology
Cataloged from PDF version of article. Background: Anti-SOX2 antibody responses are observed in about 10 to 20% of small cell lung cancer (SCLC) patients. The aim of this study was to determine whether such responses reflect a particular pattern of S
Autor:
Sukru Atakan, Burçak Vural, Canan Ulusoy, Nazlı Yalçınkaya, Leyla Bulut, Ahmet Gül, Erdem Tüzün, Hazal Haytural, Elçin Şehitoğlu, Recai Turkoglu, Elif Ugurel, Mefkure Eraksoy, Murat Kürtüncü, Filiz Çavuş, Gulsen Akman-Demir, Ali O. Gure, Melike Küçükerden, Erkingül Shugaiv, Selin Turan
Publikováno v:
Journal of Neuroimmunology
Cataloged from PDF version of article. Efforts for the identification of diagnostic autoantibodies for neuro-Behcet's disease (NBD) have failed. Screening of NBD patients' sera with protein macroarray identified mitochondrial carrier homolog 1 (Mtch1
Autor:
Mehdi Ghasemi, Semih Alpsoy, Seyhan Türk, Ümit Y. Malkan, Şükrü Atakan, İbrahim C. Haznedaroğlu, Gürsel Güneş, Mehmet Gündüz, Burak Yılmaz, Sezgin Etgül, Seda Aydın, Tuncay Aslan, Nilgün Sayınalp, Salih Aksu, Haluk Demiroğlu, Osman İ. Özcebe, Yahya Büyükaşık, Hakan Göker
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 286-292 (2016)
Objective: Multiple myeloma (MM) is currently incurable due to refractory disease relapse even under novel anti-myeloma treatment. In silico studies are effective for key decision making during clinicopathological battles against the chronic course o
Externí odkaz:
https://doaj.org/article/f4f9f90b278148459d1e22d2fc9074ff